NCT05240781招募中不适用
Zotarolimus Eluting Stent Versus Sirolimus Eluting Stent in High Bleeding Risk Angioplasty
Instituto Nacional de Cardiologia Ignacio Chavez2 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2021年9月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 280
- 试验地点
- 2
- 主要终点
- Target Lesion Failure (TLF)
研究概览
简要总结
Randomized, single-blind, single-center, non-inferiority clinical trial to compare target lesion failure (TLF) at 12 months in high bleeding risk patients who underwent elective coronary percutaneous intervention with a zotarolimus eluting stent versus a sirolimus eluting stent and short Dual Antiplatelet Therapy (DAPT).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
盲法说明
Randomized treatment will not be revealed to patient or data analyst at any time during procedure or afterwards until follow-up and analysis has been done.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 18 years old or older with an ischemic de-novo lesion(s) in coronary artery or coronary bypass graft suitable for percutaneous coronary intervention, in context of acute coronary syndrome or chronic coronary syndrome with evidence of ischemia by non-invasive study or pressure guidewire that can be treated by DES, and has at least 1 major or 2 minor Academic Research Consortium High Bleeding Risk criteria:
- •Major criteria:
- •Anticipated use of long-term oral anticoagulation
- •Severe or end-stage Chronic Kidney Disease (CKD) (eGFR <30 mL/min)
- •Hemoglobin < 11 g/dL
- •Spontaneous bleeding requiring hospitalization or transfusion in the last 6 months, or any time, if recurrent.
- •Moderate or severe baseline thrombocytopenia (<100,000/uL)
- •Chronic bleeding diathesis
- •Liver cirrhosis with portal hypertension
- •Active malignancy (excluding nonmelanoma skin cancer) within the past 12 months
- •Previous spontaneous intracranial hemorrhage
- •Previous traumatic intracranial hemorrhage within the past 12 months
- •Presence of Brain Arteriovenous malformation (AVM)
- •Moderate or severe ischemic stroke (NIHSS score equal or more than 5) within the past 6 months
- •Non-deferrable major surgery on DAPT
- •Recent major surgery or major trauma within 30 days before PCI
- •Minor Criteria:
- •Age 75 years old and older
- •Moderate CKD (eGFR 30-59 mL/min)
- •Hemoglobin 11 - 12.9 g/dL in men and 11 - 11.9 g/dL in women
- •Spontaneous bleeding requiring hospitalization or transfusion within the past 12 months, not meeting major criterion
- •Long term use of NSAIDs or steroids
- •Any ischemic stroke at any time not meeting major criterion
排除标准
- •STEMI undergoing primary PCI
- •Cardiogenic shock or resuscitation with uncertain neurological status at arrival to PCI
- •Unprotected left main lesion
- •Reference diameter larger or shorter than available stents
- •Life expectancy < 12 months
- •In-stent restenosis o thrombosis of previous stent
- •Inability to give written consent
结局指标
主要结局
Target Lesion Failure (TLF)
时间窗: 12 months
Rate of composed of cardiovascular death, myocardial infarction related to the treated vessel or ischemia driven target lesion revascularization
次要结局
- Myocardial Infarction related to the treated vessel(12 months)
- Target Vessel Revascularization(12 months)
- Non-cardiovascular death(12 months)
- Major Bleeding(12 months)
- Target Vessel Failure (TVF)(12 months)
- Cardiovascular death(12 months)
- Target Lesion Revascularization(12 months)
- Technical success(Periprocedural)
研究者
Daniel Fernando Zazueta Salido
Principal Investigator
Instituto Nacional de Cardiologia Ignacio Chavez
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic PatientsDiabetesCoronary Artery DiseaseNCT01186107Seung-Jung Park256
已完成
不适用
First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial)Ischemic StrokeNCT02578069Sino Medical Sciences Technology Inc.272
Unknown
4 期
Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real WorldCoronary Artery DiseaseNCT00768846Deutsches Herzzentrum Muenchen2,600
已完成
3 期
Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris PatientsIschemic Heart DiseaseNCT00660478Evald Hoej Christiansen2,342
已完成
4 期
Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)Coronary DiseaseNCT00133237Deutsches Herzzentrum Muenchen607